It has been reported that CD44−/CD24+ and ALDH1+ tumor cells represent two distinct tumor cell populations not only localized in different regions of the primary tumor tissue but also expressing distinct EMT and MET gene profiles (Liu et al, 2014; Colacino et al, 2018). The gene discussed is CD44; the disease is neoplasm.